
|Articles|August 1, 2004
Supplements and Featured Publications
- The Great Debate: Consensus Guidelines or Specialist Discretion for Managing Specialty Pharmaceutica
- Volume 10
- Issue 8 Suppl
The Debate
Advertisement
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Vutrisiran Improves Survival, Cardiovascular Outcomes Across Age Groups in ATTR-CM
2
Most Patients With MCL in Study of Pirtobrutinib Show Stable or Improved Physical Symptoms, QOL
3
Contributor: The Majority (57.5%) of Commercially Insured Patients Had 1 or More Chronic Conditions in 2024
4
Prior Authorization Ranked Top Barrier to Health Care Access After Cost
5










